Nexscient, Inc. Files 8-K
Ticker: NXNT · Form: 8-K · Filed: Oct 23, 2024 · CIK: 1976663
| Field | Detail |
|---|---|
| Company | Nexscient, Inc. (NXNT) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-events
TL;DR
Nexscient filed an 8-K on Oct 23rd. Details TBD.
AI Summary
Nexscient, Inc. filed an 8-K on October 23, 2024, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates Nexscient, Inc. has submitted a current report to the SEC, which may contain material updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.
Key Players & Entities
- Nexscient, Inc. (company) — Registrant
- October 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2029 Century Park East, Suite 400 Los Angeles, CA 90067 (address) — Principal executive offices
FAQ
What specific events are being reported in this 8-K filing by Nexscient, Inc.?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not specify the details of these events.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 23, 2024.
What is Nexscient, Inc.'s state of incorporation?
Nexscient, Inc. is incorporated in Delaware.
What is the principal executive office address for Nexscient, Inc.?
The principal executive office address for Nexscient, Inc. is 2029 Century Park East, Suite 400, Los Angeles, CA 90067.
What is the telephone number for Nexscient, Inc.?
The telephone number for Nexscient, Inc. is (310) 494-6620.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-10-23 06:03:33
Filing Documents
- nexscient_8k.htm (8-K) — 20KB
- nexscient_ex991.htm (EX-99.1) — 12KB
- 0001477932-24-006623.txt ( ) — 152KB
- nexscient-20241023.xsd (EX-101.SCH) — 6KB
- nexscient-20241023_lab.xml (EX-101.LAB) — 13KB
- nexscient-20241023_cal.xml (EX-101.CAL) — 1KB
- nexscient-20241023_pre.xml (EX-101.PRE) — 8KB
- nexscient-20241023_def.xml (EX-101.DEF) — 2KB
- nexscient_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events On October 23, 2024, Nexscient, Inc. (the "Company") announced that it has received approval from OTC Markets Group for its common shares to be designated as trading on the OTCQB Venture Market as of October 23, 2024 under the symbol NXNT.' OTCQB is designed for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 99.1 Press release dated October 23, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEXSCIENT, INC. Date: October 23, 2024 By: /s/ Fred E. Tannous Fred E. Tannous President & Chief Executive Officer 3